Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
H5N1 Priming and Boosting Strategies
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety, Tolerability & Immunogenicity of CSL Limited's Influenza Virus Vaccine In a Paediatric Population
- Status
- COMPLETED
- Phase
- PHASE3
A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64
- Status
- COMPLETED
- Phase
- PHASE2
Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix
- Status
- COMPLETED
- Phase
- PHASE1
H5N1 (Clade 2) Vaccination of Adults and Elderly
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine
- Status
- COMPLETED
- Phase
- PHASE4
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season.
- Status
- COMPLETED
- Phase
- PHASE3
Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant
- Status
- COMPLETED
- Phase
- PHASE1
CS-8958 Single Inhaled Dose in Elderly
- Status
- COMPLETED
- Phase
- PHASE1
Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months
- Status
- COMPLETED
- Phase
- PHASE2
Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study
- Status
- COMPLETED
- Phase
- PHASE1
Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
FLU A+B Nasal Swab Clinical Study
- Status
- COMPLETED
- Phase
- N/A
Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE3
Study to Determine a Preference for Fluzone Vaccine Given Intradermally (ID) and Intramuscularly (IM) in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE2